Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Oct 22, 2025 · Filed Oct 24, 2025
A board member of Quest Diagnostics sold $270K of Quest Diagnostics shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$270,317
Shares × reported transaction price
1 day after results of Oct 21, 2025, 82 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $181.17 on Oct 22, 2025, within 5% of its 52-week high, little changed over the previous 30 trading days
52-week range $150.33 (Jan 15, 2025) to $190.58 (Sep 30, 2025), 77% of the way up, from 250 adjusted closes. 30 trading days earlier: $180.14 on Sep 10, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.8% | -0.3% | -0.5% |
| 30 days | +5.2% | -0.8% | +6.0% |
| 90 days | +1.3% | +1.1% | +0.2% |
| 180 days | +9.1% | +4.4% | +4.7% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$1.49M of Quest Diagnostics
Scheduled in advance